Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency

This publication has 35 references indexed in Scilit:

• The EUROclass trial: defining subgroups in common variable immunodeficiency
  Blood, 2008
• Urokinase-Type Plasminogen Activator Modulates Airway Eosinophil Adhesion in Asthma
  American Journal of Respiratory Cell and Molecular Biology, 2006
• Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163*
  Critical Care Medicine, 2006
• Inhibition of Urokinase-Type Plasminogen Activator or Matrix Metalloproteinases Prevents Cardiac Injury and Dysfunction During Viral Myocarditis
  Circulation, 2006
• Common variable immune deficiency and autoimmunity
  Autoimmunity Reviews, 2006
• Plasma Levels of Intact and Cleaved Urokinase Receptor Decrease in HIV‐1‐Infected Patients Initiating Highly Active Antiretroviral Therapy
  Scandinavian Journal of Immunology, 2006
• Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?
  Thrombosis and Haemostasis, 2005
• Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro
  Journal of Leukocyte Biology, 2004
• Common variable immunodeficiency: a review
  Clinical and Experimental Medicine, 2004
• Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features
  Clinical and Experimental Immunology, 1992